Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | CA4 | P22748 | 2/20 | 0.34 |
| ▸ | CA6 | P23280 | 2/20 | 0.34 |
| ▸ | COMT | P21964 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.33 |
| ▸ | AURKA | O14965 | 1/20 | 0.33 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.33 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | BLM | P54132 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | APEX1 | P27695 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10424160 | 0.83 | MEN1 (0.36) | CA1CA2CA4CA6COMT | |
| SCHEMBL9615691 | 0.82 | CA2 (0.33) | CA1CA2CA4CA6COMT | |
| SCHEMBL31357038 | 0.82 | CA2 (0.33) | CA1CA2CA4CA6COMT | |
| SCHEMBL28142426 | 0.79 | MYC (0.38) | COMTCYP1A2LMNAPGAM1AURKA | |
| SCHEMBL5683924 | 0.78 | PGAM1 (0.45) | COMTCYP1A2LMNAPGAM1AURKA | |
| SCHEMBL9312559 | 0.75 | HSD17B10 (0.42) | CA1CA2CA4CA6LMNA | |
| SCHEMBL1070323 | 0.74 | CA2 (0.45) | CA1CA2CA4CA6CYP1A2 | |
| SCHEMBL6771382 | 0.73 | CA2 (0.33) | CA1CA2CA4CA6COMT | |
| SCHEMBL22394908 | 0.72 | MYC (0.35) | CA1CA2CA4CA6CYP1A2 | |
| SCHEMBL11056133 | 0.72 | TTR (0.37) | CA1CA2CA4CA6AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180104185-A1 | LIQUID COMPOSITIONS CAPABLE OF FOAMING AND INCLUDING ACTIVE AGENTS, AND METHODS FOR MAKING OR DEVELOPING SAME | MIKA PHARMA GMBH | 2018-04-19 | — | — | US | disclosed |
| US-9693956-B2 | Liquid compositions capable of foaming and including active agents, and methods for making or developing same | MIKA PHARMA GMBH | 2017-07-04 | — | — | US | disclosed |
| EP-2387391-B1 | METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY | MIKA PHARMA GES FÜR DIE ENTW UND VERMARKTUNG PHARMAZEUTISCHER PRODUKTE MBH (DE) | 2017-01-11 | — | — | EP | disclosed |
| US-20160022579-A1 | Liquid Compositions Capable of Foaming and Including Active Agents, and Methods for Making or Developing Same | MIKA PHARMA GMBH | 2016-01-28 | — | — | US | disclosed |
| US-9005626-B2 | Liquid compositions capable of foaming and including active agents, and methods for making or developing same | MIKA PHARMA GMBH (DE) | 2015-04-14 | — | — | US | disclosed |
| US-20110269704-A1 | METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY | MIKA PHARMA GESELLSCHAFT FUR DIE ENTWICKLUNG UND VERMARKTUNG PHARMAZEUTISCHER PRODUKTE MBH (DE) | 2011-11-03 | — | — | US | disclosed |
| US-20110059117-A1 | Liquid Compositions Capable of Foaming and Including Active Agents, and Methods for Making or Developing Same | MIKA PHARMA GMBH (DE) | 2011-03-10 | — | — | US | disclosed |
| US-20070010700-A1 | Safety containers for biologically active substances and method for producing said container | BAXTER INTERNATIONAL INC (US) | 2007-01-11 | — | — | US | disclosed |
| EP-1585679-A1 | SAFETY CONTAINERS FOR BIOLOGICALLY ACTIVE SUBSTANCES AND METHOD FOR PRODUCING SAID CONTAINER | Baxter Healthcare S.A. (CH) | 2005-10-19 | — | — | EP | disclosed |
| WO-2004063036-A1 | SAFETY CONTAINERS FOR BIOLOGICALLY ACTIVE SUBSTANCES AND METHOD FOR PRODUCING SAID CONTAINER | BAXTER HEALTHCARE S.A. (CH) | 2004-07-29 | — | — | WO | disclosed |